Inspire Medical Systems, Inc. to Report First Quarter 2024 Financial Results on May 7, 2024
April 02 2024 - 8:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release
financial results for the first quarter 2024 after the close of
trading on Tuesday, May 7. Inspire’s management team will host a
corresponding conference call beginning at 5:00 p.m. Eastern Time
to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor
Relations page of the Inspire website or through this link:
Inspire's Q1 2024 earnings call webcast. For those not planning to
ask a question of management, the Company recommends listening via
the webcast.
If you plan to ask a question, please use the following
link: Inspire's Q1 2024 earnings call. After registering, an
email will be sent, including dial-in details and a unique
conference call access code required to join the live call. To
ensure you are connected prior to the beginning of the call, the
Company suggests registering a minimum of 10 minutes before the
start of the call.
Following the call, a replay will be available on the Company's
Investor Relations website approximately two hours after the event
and archived on the site for two weeks.
About Inspire Medical SystemsInspire is a
medical technology company focused on the development and
commercialization of innovative, minimally invasive solutions for
patients with obstructive sleep apnea. Inspire’s proprietary
Inspire therapy is the first and only FDA-approved neurostimulation
technology that provides a safe and effective treatment for
moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Investor and Media ContactEzgi YagciVice
President, Investor Relationsezgiyagci@inspiresleep.com
617-549-2443
Inspire Medical Systems (NYSE:INSP)
Historical Stock Chart
From Apr 2024 to May 2024
Inspire Medical Systems (NYSE:INSP)
Historical Stock Chart
From May 2023 to May 2024